Now a Genomepatra to foretell your health
For the first time in India, find out from your saliva, what your genes can tell you about your future health. Aptly named Genomepatri, this test allows individuals to get a glimpse into what their future truly holds. All it takes is one spittle to find out about risks emerging from genetic predisposition towards various kinds of diseases. The ailments the test can foretell includes cancer, cardiovascular, metabolic diseases or neurological conditions. Through the tests, genes may, for instance, show markers for alcohol dependence or high risks for heart diseases. The results would enable an individual to promptly make lifestyle changes to preclude a genetic predisposition.
Ms Anu Acharya is the co-founder and CEO of Mapmygenome, a company that pioneered the field of personalised, preventive healthcare by making personal genomics tools available to the masses. With a vision to “Touch 100 million lives”, Mapmygenome was established in 2013, heralding the advent of improved healthcare through genomics-based personalised, precision medicine starting with India and other neglected populations.
Under her leadership, the company has been achieving several milestones, awards and honours. From the ET startup Awards to NASSCOM Emerge 50, WSJ’s Top global startups’ award, Red Herring Asia and Global to the recently conferred Pride of Telangana award; Mapmygenome has certainly become a force to be reckoned with.
A fiercely respected entrepreneur, she also serves as a governing board member and/or mentor for various high profile institutions such as the NIBMG, NIAB, IIITHyderabad, IvyCap Ventures, CSIR and ABLE. She is also a distinguished alumna from IIT Kharagpur.
Janampatri to Genomepatri - Anu Acharya 